Logo image
Control of NAD + homeostasis by autophagic flux modulates mitochondrial and cardiac function
Journal article   Open access   Peer reviewed

Control of NAD + homeostasis by autophagic flux modulates mitochondrial and cardiac function

Quanjiang Zhang, Zhonggang Li, Qiuxia Li, Samuel Aj Trammell, Mark S Schmidt, Karla Maria Pires, Jinjin Cai, Yuan Zhang, Helena Kenny, Sihem Boudina, …
The EMBO journal, Vol.43(3), pp.362-390
02/01/2024
DOI: 10.1038/s44318-023-00009-w
PMCID: PMC10897141
PMID: 38212381
url
https://doi.org/10.1038/s44318-023-00009-wView
Published (Version of record) Open Access

Abstract

Impaired autophagy is known to cause mitochondrial dysfunction and heart failure, in part due to altered mitophagy and protein quality control. However, whether additional mechanisms are involved in the development of mitochondrial dysfunction and heart failure in the setting of deficient autophagic flux remains poorly explored. Here, we show that impaired autophagic flux reduces nicotinamide adenine dinucleotide (NAD ) availability in cardiomyocytes. NAD deficiency upon autophagic impairment is attributable to the induction of nicotinamide N-methyltransferase (NNMT), which methylates the NAD precursor nicotinamide (NAM) to generate N-methyl-nicotinamide (MeNAM). The administration of nicotinamide mononucleotide (NMN) or inhibition of NNMT activity in autophagy-deficient hearts and cardiomyocytes restores NAD levels and ameliorates cardiac and mitochondrial dysfunction. Mechanistically, autophagic inhibition causes the accumulation of SQSTM1, which activates NF-κB signaling and promotes NNMT transcription. In summary, we describe a novel mechanism illustrating how autophagic flux maintains mitochondrial and cardiac function by mediating SQSTM1-NF-κB-NNMT signaling and controlling the cellular levels of NAD .
Autophagic Flux NAD+ Metabolism Mitochondrial Homeostasis Heart Dysfunction

Details

Logo image